The chromosomally encoded aminoglycoside N-acetyltransferase, AAC(2')-Ic, o
f Mycobacterium tuberculosis has a yet unidentified physiological function.
The aac(2')-Ic gene was cloned and expressed in Escherichia coli, and AAC(
2')-Ic was purified. Recombinant AAC(2')-Ic was a soluble protein of 20,000
Da and acetylated all aminoglycosides substrates tested in vitro, includin
g therapeutically important antibiotics. Acetyl-CoA was the preferred acyl
donor. The enzyme, in addition to acetylating aminoglycosides containing 2'
-amino substituents, also acetylated kanamycin A and amikacin that contain
a 2'-hydroxyl substituent, although with lower activity, indicating the cap
acity of the enzyme to perform both N-acetyl and O-acetyl transfer. The enz
yme exhibited "substrate activation" with many aminoglycoside substrates wh
ile exhibiting Michaelis-Menten kinetics with others. Kinetic studies suppo
rted a random kinetic mechanism for AAC(2')-Ic. Comparison of the kinetic p
arameters of different aminoglycosides suggested that their hexopyranosyl r
esidues and, to a lesser extent, the central aminocyclitol residue carry th
e major determinants of substrate affinity.